ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

NCI spends A Third Of Its Budget On Prevention

May 15, 1992

NCI Begins TAILORx Study.

May 26, 2006

Surgeon General plans new report, database, on tobacco.

January 16, 2004

MRI Predicts If Chemo Working In Preoperative Therapy

February 25, 2005

I-131 doses highest Near Nevada Test Site, Fallout Study Finds

November 17, 1989

In Brief: King Faisal Prize Next Year Will Be Awarded For Leukemia Research; Yarbro Wins Fulbirght

March 20, 1987